Doctor Theiss Echinacea (Solution, Tincture) Instructions for Use

Instructions
Dosage forms

ATC Code

L03AX (Other immunostimulants)

Active Substance

Echinacea (BP British Pharmacopoeia)

Clinical-Pharmacological Group

Immunostimulating drug

Pharmacotherapeutic Group

Immunostimulating agent of plant origin

Pharmacological Action

Herbal remedy. The herb of Echinacea purpurea contains water-soluble immunostimulating polysaccharides (4-O-methylglucuronoarabinoxylans, acidic arabinorhammogalactans); essential oils (components include germacrene alcohol, borneol, bornyl acetate, pentadeca-8-en-2-one, germacrene D, caryophyllene, caryophyllene epoxide); flavonoids (ferulic acid and its derivatives, including cichoric acid, methyl ester of cichoric acid, 2-O-caffeoyl-3-O-feruloyl-tartaric acid, 2,3-O-diferuloyl-tartaric acid, 2-O-caffeoyl-tartaric acid); alkamides; polyenes.

It has immunomodulatory and anti-inflammatory effects. Polysaccharides increase the phagocytic activity of neutrophils and macrophages and stimulate the production of interleukin-1. The complex of active substances induces the transformation of B-lymphocytes into plasma cells and improves the functions of T-helpers. Due to inulin, levulose, and betaine, it improves metabolic processes, especially in the liver and kidneys. It increases the body’s nonspecific resistance (including to influenza and herpes pathogens). It has a capillary-protective effect.

Indications

Enhancement of nonspecific defense factors in uncomplicated acute infectious diseases and in predisposition to frequent colds; for immune stimulation in patients with uncomplicated acute infectious diseases (as an auxiliary treatment); prevention of ARVI and influenza; as an auxiliary medicinal product during prolonged antibiotic therapy of chronic infectious diseases. Prevention and as part of complex therapy for recurrent infectious diseases of the respiratory tract and urinary tract.

ICD codes

Open the list of ICD codes

ICD-10 code	Indication
J06.9	Acute upper respiratory infection, unspecified
J10	Influenza due to identified seasonal influenza virus
Z29.8	Other specified prophylactic measures

ICD-11 code	Indication
1E30	Influenza due to identified seasonal influenza virus
CA07.0	Acute upper respiratory tract infection of unspecified site
QC05.Z	Prophylactic measures, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer the oral solution or tincture undiluted. Hold the liquid in the mouth for a few seconds before swallowing.

For acute infection treatment, initiate therapy at the first sign of symptoms. Take 2.5 ml of the solution three times daily.

For preventive use during periods of increased risk of respiratory infections, take 2.5 ml of the solution three times daily. Limit continuous prophylactic use to a maximum of 8 weeks.

The total daily dosage should not exceed 7.5 ml.

Adhere strictly to the recommended duration of use. Do not exceed 10 consecutive days for treating acute conditions without consulting a physician.

This product is contraindicated in children under 12 years of age, during pregnancy, and while breastfeeding.

Discontinue use immediately and seek medical attention if signs of an allergic reaction occur, such as skin rash, itching, or difficulty breathing.

Adverse Reactions

From the digestive system: nausea, vomiting, stool disorders.

From the hematopoietic system: leukopenia (with continuous use for more than 8 weeks).

From the immune system: skin rash, itching, angioedema, Quincke’s edema, Stevens-Johnson syndrome, anaphylactic shock. Allergic reactions are possible in patients with atopy. A relationship between the occurrence of adverse events and autoimmune diseases (diffuse encephalitis, erythema nodosum, immunothrombocytopenia, Evans syndrome, Sjögren’s syndrome with renal tubular dysfunction) has been reported.

From the cardiovascular system: dizziness, decreased blood pressure.

From the respiratory system: bronchospasm with obstruction and asthma attacks as manifestations of hypersensitivity reactions.

Allergic reactions: hyperemia, swelling.

Other: chills.

Contraindications

Hypersensitivity to Echinacea and plants of the Asteraceae family; progressive systemic and autoimmune diseases (including tuberculosis, sarcoidosis, collagenosis, multiple sclerosis); immunodeficiency (AIDS or HIV infection) and immunosuppression (including cytostatic anticancer therapy; history of organ or bone marrow transplantation); blood diseases (agranulocytosis, leukemia); allergic diseases (urticaria, atopic dermatitis, bronchial asthma); children under 12 years of age; pregnancy, breastfeeding period.

Use in Pregnancy and Lactation

Contraindicated for use during pregnancy and breastfeeding.

Pediatric Use

Contraindicated for use in children under 12 years of age.

Special Precautions

Patients with recurrent infectious diseases of the respiratory tract require regular medical supervision.

Patients with atopy have an increased risk of developing anaphylactic shock.

Drug Interactions

With simultaneous use of Echinacea preparations with immunosuppressants, mutual weakening of the effect occurs.

Simultaneous use with antibiotics and other antimicrobial agents is possible.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer